TVAGF yields 235.29% · JNJ yields 2.13%● Live data
📍 TVAGF pulled ahead of the other in Year 1
Combined, TVAGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TVAGF + JNJ for your $10,000?
TVA Group Inc. operates a communications company in Canada. It operates through four segments: Broadcasting, Magazines, Film Production & Audiovisual Services, and Production & Distribution. The company's Broadcasting segment creates, produces, and broadcasts entertainment, sports, news, and public affairs programming, as well as engages in commercial production; operates a French-language television network; markets digital products associated with various televisual brands; and provides custom publishing and specialty services. Its Magazines segment publishes magazines in various fields, such as the arts, entertainment, television, fashion, and decoration; and markets digital products associated with various magazine brands. The company's Film Production & Audiovisual Services segment offers soundstage, mobile, and equipment rental services, as well as dubbing and described video, postproduction and visual effects. Its Production & Distribution segment produces and distributes television shows, movies, and television series worldwide. The company was formerly known as Télé-Métropole Inc. and changed its name to TVA Group Inc. in February 1998. TVA Group Inc. was incorporated in 1960 and is headquartered in Montreal, Canada. TVA Group Inc. is a subsidiary of Quebecor Media Inc.
Full TVAGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.